Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK-based MMF Dosing for GVHD Prophylaxis in Pediatric BMT
NCT01487577Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Jun 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mycophenolate mofetil in graft-versus-host disease (GVHD), sponsored by University of Pittsburgh. Started Jun 2010; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01487577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01487577.